What is it about?
To improve drug discovery, this paper introduces a new method that combines different virtual screening techniques using machine learning. Virtual screening helps identify potential drug candidates from large chemical libraries. This method was tested on various protein targets, using different scoring techniques like QSAR, Pharmacophore, docking, and 2D shape similarity. They combined these scores into one overall score. This approach, which includes a new ranking formula called “w_new,” performed better than using the individual methods alone.
Featured Image
Photo by freestocks on Unsplash
Why is it important?
To improve drug discovery, this paper introduces three key innovations: W_new Metric: A new formula, "W_new," evaluates machine learning models, indicating high performance, low error rates, and reduced overfitting risk. Consensus Virtual Screening: A workflow combining four screening methods enhances the accuracy and efficiency of identifying the best drug candidates. Bias Assessment Workflow: A method to measure and reduce bias between active and decoy compounds, validated with benchmark datasets, ensuring robust machine learning models.
Perspectives
Read the Original
This page is a summary of: Consensus holistic virtual screening for drug discovery: a novel machine learning model approach, Journal of Cheminformatics, May 2024, Springer Science + Business Media,
DOI: 10.1186/s13321-024-00855-8.
You can read the full text:
Contributors
The following have contributed to this page